BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1464 related articles for article (PubMed ID: 12803340)

  • 1. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of HLA matching and associated factors on aortic valve homograft function.
    Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
    J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yii M
    Heart Surg Forum; 2008; 11(1):E42-5. PubMed ID: 18270140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction.
    Pompilio G; Polvani G; Piccolo G; Guarino A; Nocco A; Innocente A; Porqueddu M; Dainese L; Veglia F; Sala A; Biglioli P
    Ann Thorac Surg; 2004 Aug; 78(2):557-63. PubMed ID: 15276519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts.
    Oei FB; Stegmann AP; van der Ham F; Zondervan PE; Vaessen LM; Baan CC; Weimar W; Bogers AJ
    J Heart Valve Dis; 2002 May; 11(3):315-24; discussion 325. PubMed ID: 12056721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yiil M
    J Heart Valve Dis; 2006 Jul; 15(4):540-4. PubMed ID: 16901051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation.
    Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML
    Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
    Meyer SR; Campbell PM; Rutledge JM; Halpin AM; Hawkins LE; Lakey JR; Rebeyka IM; Ross DB
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):554-60. PubMed ID: 15784350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.